Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections

Author:

Ioannou Petros1ORCID,Baliou Stella1,Samonis George12

Affiliation:

1. School of Medicine, University of Crete, 71003 Heraklion, Greece

2. First Department of Medical Oncology, Metropolitan Hospital of Neon Faliron, 18547 Athens, Greece

Abstract

The development of antimicrobial resistance (AMR), along with the relative reduction in the production of new antimicrobials, significantly limits the therapeutic options in infectious diseases. Thus, novel treatments, especially in the current era, where AMR is increasing, are urgently needed. There are several ongoing studies on non-classical therapies for infectious diseases, such as bacteriophages, antimicrobial peptides, and nanotechnology, among others. Nanomaterials involve materials on the nanoscale that could be used in the diagnosis, treatment, and prevention of infectious diseases. This review provides an overview of the applications of nanotechnology in the diagnosis and treatment of infectious diseases from a clinician’s perspective, with a focus on pathogens with AMR. Applications of nanomaterials in diagnosis, by taking advantage of their electrochemical, optic, magnetic, and fluorescent properties, are described. Moreover, the potential of metallic or organic nanoparticles (NPs) in the treatment of infections is also addressed. Finally, the potential use of NPs in the development of safe and efficient vaccines is also reviewed. Further studies are needed to prove the safety and efficacy of NPs that would facilitate their approval by regulatory authorities for clinical use.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference241 articles.

1. Michaud, C.M. (2009). Encyclopedia of Microbiology, Elsevier.

2. Trends in Infectious Disease Mortality in the United States during the 20th Century;Armstrong;JAMA,1999

3. The Australian Mortality Decline: Cause-Specific Mortality 1907–1990;Taylor;Aust. N. Z. J. Public Health,1998

4. GBD, and 2019 Child and Adolescent Communicable Disease Collaborators (2023). The Unfinished Agenda of Communicable Diseases among Children and Adolescents before the COVID-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019. Lancet Lond. Engl., 402, 313–335.

5. Antimicrobial Resistance Collaborators (2022). Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet Lond. Engl., 399, 629–655.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3